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INSTITUTION : University eye clinic (Hopitul de la Croix Rousse) + Department of 
radiotherapy (Cenw hospit&% Lyon -5) 
Putpose : To &scribe macroscopic results. survival, causes of enucleadons and 
survival in enucleated patients. complications and functicmal nsulu. 
Melhod : Radio active applications of ruthenium 106 made in France, have 
teen used from 1983 to 1990 and then East-German applications 
since 1991 till 1993. ‘fhe catculutions of the doses allow delivering 
a minimal dose of 60 gys to the tumor. 
Results : The complete regression tu a tinal level of height of at least 2mm 
showed that TIT2 tumors (IO3 eyes) were the most numerous. 
Specific survival was 82.92 40 at 5 years (+ or - 3.17). 
Conclusion : I- The limitations of the indications of ru 106 to tumors witi 
height nut > 7 mm is patally theoretical 2. The survival specitic 
mtes at 5 years an campamble to those of Lomnaech and Gragouda. 
3. The scwdary complications due to ru 106 are limited. 
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CONSERVATlVETHERAPYOFUNILATERALRET!NOBLASTOMA 
KANEKOA.MOORIM.andINOMATAM. 
1 Division of Ophthalmology, National Cancer Center Hospital (Japan) 
2 Department of Radiology, Tokai University Hospital (Japan) 
3 Department of Pharmacology, National Cancer Cater Research institute 
(Japan) 
Purpose: Is our method of conservative therapy of advanced unilateral 
retinoblastoma effective and safe? 
Methods: From lYYO-1993, 38 cases of unilutcrdl retinoblastoma were treated 
in National Cancer Center Hospital in Tokyo. Except for Y eyes with absolute 
glaucoma, suspicious extraocular extension or refusal of conservative 
therapy, all of them were treated conservatively. Ocular hypcrthetmia using 
Lagendijk’s applicator wwc combined with radiotherapy, selective 
t,, ophthalmic aaerial injection by balloon catheter or vitreous injection of a 
small amount of melphalan. 
Results: All except one of them could be preserved successfully and some of 
them retain useful visual acuity. One case of systemic metastasis was found 
in spite of successful ocular cure up to April 1995. In this case, it is 
considered that metastusis could have occurred if the eyeball was enucleated, 
because of subclinical hcmatogcnous metastasis bcforc treatment. 
Conclusion: Most of unilateral rctinoblastoma are possible to bc cured 
without cnuclcation by our method using ocular hyperthermia combined with 
radiotherapy or chemotherupy. 
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Backgmund : The PET examination allows for the location of many melanomas. 
By malignant melanomas, it is the glucose metabolism which has 
been profoundly pathoIugicalIy changed (as has been proved with 18 
F - 2 - Fluom - 2 -dewy - D - Glucose). 
Patients : From November 1994 - March 1995,6 p&ems - 2 wumen and 4 
men - who had primacy intraocular malignant melanoma were 
examined with Positron Emission Tomography in cooperation wirh the Nuclear 
Medicine Clinic. The echographically detenined base diameter of the tumws was 
between 95 and 16,s mm and their prominence was between 3.7 and 7.7 mm. In one 
patient a relapse occurred afler previous Ruthenium radiatica treatment 
Results : 
Patients: 
A positive increase occurred in 5 of the 6 PET examinations. 
The malignant uuno~s were easy 10 identify and recongnize with a 
prominence of 3.7 - 7,7 mm. No increase was found in the patient 
who had ex$erienced a retapse following Ruthenium radiation 
Conclusions : Primary uveat melanoma con be indent&d through PET 
examination in a small series of 6 patienls with a pominence of 3,7 
mm. It is uncertain - and therefore still open for discussion - why 
the patient with a relapse following Ruthenium radialian reaunent 
did not experience positive increases following PET exa!&xions. 
An explanation for this could be the small number of me@oIicaJly 
active wnor cells and / m-the reduced metabolic activity after 
previous radiation txatment 
TITLE: PSYCHOLOGICAL CONSEQUENCES OF CHOROIDAL 
MELANOMA 
AUTHORS : BRANDBERG Y.. KOCK E. , SERFXiARD S. , AF TRAMPE E. 
INSTITUTION : OPHTALMIC PATHOLQGY AND ONCOLOGY SERVICE. S:T 
ERIKS EYE HOSPITAL 
PUl-psC: To investigate long and short term psychological and pradcal 
cxmsequenccs ofchomidal melanoma trated with em&&m vs. 
rddinactive plaque +empy. Quality of life is also studied. 
Methods : 
WW 
Consecutive newly diagnosed patients with chomidal melanoma .a% 
asked to complete Ihe Hospital Anxiety and Depression Scale 
at their fust visit tu the eye clinic. At three-months follow-up and 
one and two years afta the. diagnosis, they arc intaviewai 
concerning the psychological, cosmetic and practical ccmsequence-s 
of the diseaw and treamxnt in connection to Ihe interviews. 
questiamaires (“HAD”, EORTC QLQ-33”. “Impact of Event 
kale”) are completed. 
Results : The study started in January -9.5 and are planned to include 100 
patients. Twenty-one ptients have so far (June 95) been included. 
No one declined participation in Ihe nudy, but one patient was 
excluded due to mc(astatic disease. The &sign of the study and some 
pmlimiwy data will lx pesented. 
concl”sion : No conclusions can Ix drawn, since. this is an ongoing study. 
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